This webinar will enable you to better characterize the maximum tolerated dose to improve your probability of success in later trials.

At the end of the webinar you will be able to:

  • Simulate and analyse Phase 1 dose escalation trials for determining maximum tolerated dose (MTD)
  • Understand a range of different methodologies that are used in Phase 1 dose escalation trials
  • Communicate findings to the clinical team using East’s intuitive graphs and tables
  • Simulate a dose escalation design followed by single-arm cohort expansion


  • Pantelis Vlachos, Principal, Strategic Consulting, Cytel

Click here for additional information and registration details.

Related Content

Evidence Matters 2022

Evidence Matters 2022

Evidence Matters is a virtual one-day summit that brings the literature review community together from different industries to learn, engage, and solve ever-pressing evidence-based research challenges.